Signal
Midi Health Diversifies into Hormone-Informed Skin Care to Capture Perimenopausal Consumer Segments

Summary
Telehealth leader Midi Health is expanding its clinical scope by launching a topical skin and body care line. Led by Chief Science Officer Dr. Kathleen Jordan, the move integrates aesthetic concerns with medical-grade menopause management to increase patient lifetime value.
The launch adds another player to Menopause & Midlife and Digital Health/Telehealth. The things to watch are where it will be sold, what it costs, and who can actually get it.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.
